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Dear Editor: Cervical chondrocutaneous branchial remnants (CCBRs) are rare, congenital, benign neck masses, and are derived from dislocated branchial apparatus components comprised of cartilage tissues 1 .
Herein, we describe a 44-year-old female who presented with a solitary asymptomatic skin-colored nodule on the lower part of right side of the neck anterior to SCM (Fig.  1A) . The patient denied any history of trauma, surgery, or injection. No remarkable findings except for the skin lesion were observed. Ultrasonography showed a hyperechoic nodule (0.8×0.3 cm) in the subcutaneous layer; No internal vascularity, fistula, or sinus connection with the deep underlying structures of the neck was found (Fig.  1B) . Histopathological examination after surgical excision showed a hyaline cartilage core in the dermis with isogenous chondrocytes, a glassy extracellular matrix and absence of elastic fiber, which characterize hyaline cartilage (Fig. 1C, D) . A diagnosis of CCBR was confirmed, and the patient showed no recurrence during 9 months of follow-up. Thus, detailed additional examinations, such as abdominal and cardiac ultrasonography, are recommended for patients with CCBRs. However, the prevalence of asso- We received the patient's consent form about publishing all photographic materials. Although the cause remains uncertain, the presence of hyaline cartilage in CCBRs can be considered a favorable marker, indicating a low possibility of associated anomalies. This rare case involving a CCBR comprised of hyaline cartilage further supports the current knowledge regarding the embryogenesis and associated anomalies of CCBRs.
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Dear Editor:
A 75-year-old woman presented with generalized erythematous pruritic patches and papules on the face, neck and both extremities which occurred 2 months ago. The patient has developed Idiopathic pulmonary fibrosis (IPF) for 10 years and she was treated with pirfenidone 5 months ago with good tolerability. No adverse effect was reported during the first 3 months of administration, and the dose of pirfenidone was gradually increased from 600 mg/day to 1,200 mg/day for the symptom control. Skin rash initially developed in the sun exposed areas, but gradually spread to the whole body. Punch biopsy was performed on the dorsum of right hand (Fig. 1) . We received the patient's consent form about publishing all photographic materials. Histopathology revealed lichenoid interface dermatitis, focal parakeratosis, and necrotic keratinocytes, which was consistent with lichenoid drug eruption (Fig.  2) . The patient was initially treated with oral and topical steroid, but oral steroid was discontinued due to recurrent infection. Respiratory physician reduced the dose of pirfenidone to 600 mg/day. After the dose reduction, symptoms have been controlled by topical steroids. IPF is a progressive, fibrotic lung disease with poor prognosis. Median survival is 3∼5 years without effective therapy 1 .
Pirfenidone is an oral antifibrotic agent which inhibits tumor necrosis factor-α and transforming growth factor-β with therapeutic effect for IPF. The primary treatment-related adverse events associated with pirfenidone are gastrointestinal upset, skin eruption. The skin eruption associated with pirfenidone has been reported in several cases related to photosensitivity, but no lichenoid drug eruption has been reported 2 .
